Latest news with #Signum
Mid East Info
19-05-2025
- Business
- Mid East Info
Signum Aviation achieves a King's Award for Enterprise - Middle East Business News and Information
Signum Aviation, the UK-based flight planning and operational support specialist for the private aviation industry has been honoured with a King's Award for Enterprise in the International Trade category, announced 6 May, 2025. These Awards are the most prestigious award a UK company can receive. His Majesty The King approves the winners, which recognises companies of all sizes. Signum has also been active in Riyadh, Saudi Arabia, located at the General Aviation private terminal since January this year, identifying the Kingdom as a ripe and expanding market. Awais Babar leads Signum Aviation in the Middle East as Regional Vice President. He has led a number of projects in the region and is now based in Riyadh. 'We are honoured to have been chosen for this special award,' said Jonathan Gill, managing director and founder, Signum Aviation. 'It is a terrific achievement and underscores our commitment to our valued clients across the globe. I would like to thank our dedicated and proactive team who continue to work tirelessly and with the upmost professionalism every day to make our business successful.' Founded by Jonathan in 2007, the business has grown substantially from a small office in Chester in the UK and just one client, to a global business supporting over 300 aircraft tails around the world each year. Aircraft types supported range in size from the Pilatus PC-12 through to the Boeing 777. Its facility at Manchester's City Airport, UK and Riyadh is complemented by locations in Denver, USA and Subang, Malaysia. Signum Aviation has become a benchmark company in the business aviation industry, providing flight planning and operations support to an international client base spanning the Middle East, North America, Europe, Africa and China. Its clients include Heads of State, government aircraft and many high-net-worth individuals across the globe. The company specialises in providing a personalised service offering tailored and flexible support to its customers on a 24/7 basis. Its service portfolio consists of providing flight planning, handling setup, overflight and landing permits, weather briefings and runway analysis, as well as airfield performance, flight watch services and third-party charters. The Award programme, now in its 59th year, is the most prestigious business award in the UK. The King's Awards for Enterprise, previously known as The Queen's Awards for Enterprise, were renamed in 2023 to reflect His Majesty The King's desire to continue the legacy of HM Queen Elizabeth II's by recognising outstanding UK businesses. The awards celebrate the success of exciting and innovative businesses which are leading the way with pioneering products or services, delivering impressive social mobility programmes, or showing their commitment to excellent sustainable development practices.
Local Sweden
30-04-2025
- Politics
- Local Sweden
How immigration is fuelling the growth of the Catholic Church in Sweden
This week's episode of Sweden in Focus Extra for Membership+ subscribers features an interview with Magdalena Dahlborg, an editor for a Swedish-language Catholic magazine. Advertisement How did the Catholic Church in Sweden recover from the brink of extinction and what role does it play in Swedish public life today? The Local's deputy editor Becky Waterton raised these questions in a conversion she had recently with Magdalena Dahlborg about the history of the Catholic Church in Sweden. Dahlborg is the author of a book on Catholicism and an editor for the Swedish Catholic magazine Signum. In this episode she talks about the huge role immigrants have played in the growth of the church in recent decades, how important she thinks the church can be for helping immigrants to integrate in Sweden, and why she hopes the Swedish Cardinal Anders Arborelius isn't named as the new pope. Membership+ subscribers can listen to the interview in the latest episode of Sweden in Focus Extra, out April 30th. READ ALSO: Get Membership+ to listen to all The Local's podcasts Sweden in Focus Extra is a podcast for The Local's Membership+ subscribers. Sign up to Membership+ now and get early, ad-free access to a full-length episode of the Sweden in Focus podcast every weekend, as well as Sweden in Focus Extra every Wednesday. Please visit the link that applies to you and get a 40% discount on Membership+ Read more about Membership+ in our help centre. Already have Membership+ but not receiving all the episodes? Go to the podcast tab on your account page to activate your subscription on a podcast platform. If you prefer to listen on the site, you can find all episodes at the bottom of our podcast page.
The Guardian
10-04-2025
- Entertainment
- The Guardian
Ravel: Complete Songs album review – fine performances for the composer's 150th anniversary
After collections devoted to Duparc, Fauré and Poulenc, pianist Malcolm Martineau adds Ravel to the surveys of French song he has curated for Signum, nicely timed for the composer's 150th anniversary this year. As before, Martineau is partnered by a lineup of mostly British singers, who tackle the songs as if determined to demonstrate that this repertoire should never be seen as the exclusive preserve of Francophone artists. The settings, 37 of them altogether, are arranged chronologically across the two discs, from the Ballade de la Reine Morte d'Aimer (Ballad of the Queen Killed by Love), which Ravel composed in 1893 when he was just 18 but already showing the fastidious ear for texture and colour that would characterise all his music, to the three settings that make up Don Quichotte à Dulcinée, originally commissioned for a film by Pabst starring the great Russian bass Chaliapin, but belatedly completed in 1934, three years before Ravel's death. Martineau is of course the common denominator through the discs, whether evoking the shimmering orchestral colours in the piano version of Shéhérazade (which does, though, recruit a flute for the second number, La Flûte Enchantée), the rustic humour of the Chants Mélodies Populaires Grecques, or the pictorial impressions of Histoires Naturelles, while the exquisite Trois Poèmes de Stéphane Mallarmé are performed in Ravel's original instrumentation with the soprano partnered by two flutes, two clarinets and string quartet. For many, though it will be the one-off songs, those that do not form part of a well-known cycle or set, that are the big discoveries here, whether it's the early, bleak setting of Verlaine, Un Grand Sommeil Noir from 1895, or the touching little Tripatos from 1909, an arrangement of a Greek folk song that Ravel composed after his father's death. But among the better known numbers there are some fine performances, as well as a few disappointments: the soprano Paula Murrihy brings a real sultry intensity to Shéhérazade, and baritone Simon Keenlyside finds precisely the right light touch for the epigrammatic Histoires Naturelles, while the mezzo Julie Boulianne proves more convincing in the Mallermé settings than she is in Chansons Madécasses, perhaps the greatest of all Ravel's vocal works. In the end, though, there are far more treats here than disappointments. This article includes content hosted on We ask for your permission before anything is loaded, as the provider may be using cookies and other technologies. To view this content, click 'Allow and continue'. Listen on Apple Music (above) or Spotify
Associated Press
12-03-2025
- Business
- Associated Press
Signum Surgical Appoints Carol Burns as CEO
GALWAY, Ireland--(BUSINESS WIRE)--Mar 12, 2025-- Signum Surgical, ('Signum' or 'the Company') the medical technology company developing innovative solutions to treat colorectal diseases, is pleased to announce the appointment of Ms. Carol Burns as Chief Executive Officer. This press release features multimedia. View the full release here: Carol A. Burns, CEO, Signum Surgical (Photo: Business Wire) Ms. Burns' appointment is a pivotal milestone for Signum, as the Company initiates commercialization of BioHealx ®, a first-of-its-kind medical device for the treatment of anal fistula, a painful and debilitating colorectal condition that affects one in 5,000 people worldwide 1. Commercialization follows U.S. FDA Food and Drug Administration (FDA) De Novo clearance for BioHealx in 2024. The BioHealx device safely closes anal fistulas with a bioabsorbable implant that creates tissue apposition for primary healing, reducing lengthy and costly repeat procedures and diminishing the incidence of incontinence. With a distinguished career in the medical device industry, Carol has a proven track record of over 25 years founding, leading and successfully commercializing innovative therapies which include serration angioplasty, endovascular abdominal aortic aneurysm, and endoscopic vein harvesting. She previously co-founded and served as CEO of both Cagent Vascular and Intact Vascular. Additionally, she has held leadership positions at Embrella Cardiovascular (acquired by Edwards Lifesciences), Animas (acquired by Johnson & Johnson), Ventrica (acquired by Medtronic), and Guidant Corporation. Carol Burns, CEO, Signum Surgical, commented: 'I am delighted to join the Signum Surgical team to lead its next phase of growth. This innovative technology is the first treatment of fistula-in-ano which directly closes the fistula tract by tissue apposition, without sacrificing sphincter muscle function. We believe this technology will become the standard of care for the management of fistula-in-ano while also preserving fecal continence. The First-in-Human (FIH) study results, to be published later this year, showed excellent primary healing with no recurrence at 12+ months. Our commercial plan includes a Post Market Surveillance Study to build upon the FIH experience. We are excited to bring this novel treatment to market for the benefit of patients, surgeons, and the healthcare system.' Eoin Bambury, Co-Founder and Chief Technology Officer, added: 'With a proven track record of introducing innovative technologies, commercializing products in highly specialized fields and driving strategic growth, Carol is an ideal fit to lead the commercialization of BioHealx and our next phase of development.' Moshe Zilversmit, Co-Founder and Chief Innovation Officer, commented: 'Carol's deep expertise in the medical device industry and unwavering dedication to improving patient outcomes, aligns perfectly with our mission to revolutionize the surgical management of fistula-in-ano. We are delighted to have her on board.' About Anal Fistulas Anal fistula disease occurs more often in men, ages 18-50. Fistulas have complicated pathogenesis resulting in poor quality of life due to frequent recurrence, fecal incontinence, abscess, odor, and pain. Fistulas were first described by Hippocrates over 2,500 years ago, yet surgical procedures are often associated with suboptimal treatment results including incontinence and the need for repeat procedures due to recurrence. About BioHealx Technology The Signum Surgical BioHealx ® Anal Fistula Device is designed to close the fistula tract by tissue apposition to deliver primary healing. The device contains a single synthetic absorbable implant in the shape of a helical coil, preloaded into a special purpose single use delivery system. The device is designed for introduction and implant delivery under direct visualization. The BioHealx device has received FDA De Novo 510(k) Clearance. Signum Surgical, USA, Inc 175 Strafford Avenue, Suite 1 Wayne, PA 19087 Email: [email protected] Signum Surgical, LTD New Docks, The Docks Galway, Ireland, H91E2HV Media Contacts: FTI Consulting Patrick Berkery / Rugile Nenortaite Tel: +353 86 602 5988 / +353 86 277 9905 Email: [email protected] SOURCE: Signum Surgical Copyright Business Wire 2025. PUB: 03/12/2025 06:00 AM/DISC: 03/12/2025 06:00 AM
